2023
Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors
Slotkin R, Kyriakides T, Kundu A, Stack G, Sutton R, Gupta S. Correlation of a commercial platform’s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors. PLOS ONE 2023, 18: e0289713. PMID: 37643190, PMCID: PMC10464955, DOI: 10.1371/journal.pone.0289713.Peer-Reviewed Original Research
2018
Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel
Kiros Y, Elinav H, Gebreyesus A, Gebremeskel H, Azar J, Chemtob D, Abreha H, Elbirt D, Shahar E, Chowers M, Turner D, Grossman Z, Haile A, Sutton R, Maayan S, Wolday D. Identification and characterization of HIV positive Ethiopian elite controllers in both Africa and Israel. HIV Medicine 2018, 20: 33-37. PMID: 30318718, PMCID: PMC6510948, DOI: 10.1111/hiv.12680.Peer-Reviewed Original ResearchConceptsStable CD4 countsElite controllersCD4 countAntiretroviral treatmentIsraeli cohortAfrican cohortART-naïve subjectsHIV elite controllersLarge African cohortHIV-positive patientsUndetectable viral loadCells/μLWarrants further investigationEthiopian patientsViral loadOverall prevalenceCohortPatientsPrevalenceFirst cohortUnique subgroupPossible environmental factorsSignificant differencesHomogenous populationSelection bias